SBC Medical Group (NASDAQ:SBC – Get Free Report) was upgraded by analysts at Wall Street Zen to a “strong-buy” rating in a research note issued to investors on Saturday.
SBC Medical Group Trading Down 7.3%
SBC stock opened at $4.31 on Friday. SBC Medical Group has a twelve month low of $2.62 and a twelve month high of $12.50. The company has a debt-to-equity ratio of 0.03, a current ratio of 4.44 and a quick ratio of 4.40. The firm has a 50 day simple moving average of $4.04 and a 200-day simple moving average of $4.48.
SBC Medical Group (NASDAQ:SBC – Get Free Report) last released its quarterly earnings results on Thursday, May 15th. The company reported $0.21 earnings per share for the quarter, topping analysts’ consensus estimates of $0.11 by $0.10. The company had revenue of $47.33 million for the quarter, compared to analyst estimates of $51.52 million. As a group, sell-side analysts expect that SBC Medical Group will post 5.02 EPS for the current year.
SBC Medical Group Company Profile
SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand.
Further Reading
- Five stocks we like better than SBC Medical Group
- Dividend Capture Strategy: What You Need to Know
- New All-Time Highs Coming for Broadcom? Wall Street Says Yes
- What Are Dividend Achievers? An Introduction
- Overheated Market? Analysts Watch These Red Flags
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- 3 Reasons AMD Could Be the Hottest Stock of the Summer
Receive News & Ratings for SBC Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SBC Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
